Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Miller, K. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Miller, K. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 89, No. 1 17-31
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia

Molecular and Basic Mechanisms of Anaesthesia

The nature of sites of general anaesthetic action

K. W. Miller

*Department of Anaesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 and the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA*Address for correspondence

Abstract

Br J Anaesth 2002; 89: 17–31


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
J. W. Sear
What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach
Br. J. Anaesth., July 1, 2009; 103(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. C. Sewell and J. W. Sear
Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics.
Anesth. Analg., March 1, 2006; 102(3): 764 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. C. Sewell and J. W. Sear
Derivation of Preliminary Three-Dimensional Pharmacophores for Nonhalogenated Volatile Anesthetics
Anesth. Analg., September 1, 2004; 99(3): 744 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. C. Sewell and J. W. Sear
Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anaesthetics{dagger}
Br. J. Anaesth., January 1, 2004; 92(1): 45 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Bali and M. H. Akabas
Defining the Propofol Binding Site Location on the GABAA Receptor
Mol. Pharmacol., January 1, 2004; 65(1): 68 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Harris, A. R. Graber, and M. Covarrubias
Allosteric modulation of a neuronal K+ channel by 1-alkanols is linked to a key residue in the activation gate
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C788 - C796.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
B. W. Urban
Current assessment of targets and theories of anaesthesia
Br. J. Anaesth., July 1, 2002; 89(1): 167 - 183.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.